Cost-Effectiveness of Screening for Pre-Diabetes Among Overweight and Obese U.S. Adults
Author(s) -
Jaro Wex Wechowski
Publication year - 2008
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc07-2363
Subject(s) - medicine , diabetes mellitus , overweight , impaired glucose tolerance , context (archaeology) , impaired fasting glucose , type 2 diabetes , cost effectiveness , obesity , endocrinology , paleontology , risk analysis (engineering) , biology
I read with great interest the article by Hoerger et al. regarding cost-effectiveness of screening for pre-diabetes in the U.S. setting (1). The results reported by the authors have potentially global implications and should be viewed in the context of similar analyses conducted elsewhere.The cost-effectiveness ratio obtained in the study is in broad agreement with recent findings for the U.K. (2). The U.K. analysis was based on a pre-diabetes screening module linked to a validated diabetes model (3). The value of the incremental cost-effectiveness ratio (ICER) was determined as £23,717 for patients with both impaired glucose tolerance and impaired fasting glucose treated with intensive …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom